Megan Blunda in Bend, Oregon

Medical School: Georgetown University School Of Medicine
Graduation Year: 2011
The Primary Medical Specialty for Megan Blunda is listed as: Family Practice
Approximate Years of Experience: 13
PAC (PECOS ID)#: 2466673736
NPI #: 1235424334
NPI Created On: 06/16/2011
NPI Last Updated Listed as: 01/29/2021
Primary Taxonomy Code: 207Q00000X
License Number:
MD188753
Listed Gender: Female

Forms of insurance accepted by include, but are not limited to:

• Humana
• Moda Health Plan, Inc.
• PacificSource Health Plans
• Providence Health Plan
• Medicare

They are listed as accepting new patients in some locations.

Languages spoken by staff include: English, Spanish.

Services and Procedures include:

1. Insertion of needle into vein for collection of blood sample
2. Blood test, comprehensive group of blood chemicals
3. Blood test, lipids (cholesterol and triglycerides)
4. Manual urinalysis test with examination using microscope
5. Vitamin d-3 level
6. Hemoglobin a1c level
7. Blood test, thyroid stimulating hormone (tsh)
8. Complete blood cell count (red cells, white blood cell, platelets), automated test
9. Vaccine for influenza for injection into muscle
10. Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older
11. New patient office or other outpatient visit, typically 45 minutes
12. Established patient office or other outpatient visit, typically 15 minutes
13. Established patient office or other outpatient, visit typically 25 minutes
14. Established patient office or other outpatient, visit typically 40 minutes
15. Administration of influenza virus vaccine
16. Administration of pneumococcal vaccine
17. Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment
18. Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit
19. Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit
20. Hepatitis c antibody screening, for individual at high risk and other covered indication(s)